Registration is Open for #ASPHO2021!

Review of APHON/ASPHO SCD Transition Position Paper

Posted February 19, 2021

An update to The Transition of Patients with Sickle Cell Disease from Pediatric to Adult Health Care Position Paper jointly developed in 2014 by the Association of Pediatric Hematology/Oncology Nurses (APHON) and ASPHO is underway.

ASPHO and APHON are inviting comments before final approval and publication. Members can review the updated position statement and submit comments by Monday, March 8.

ASPHO Advocacy 2021 Webinar

Posted February 3, 2021

Learn about ASPHO's advocacy priorities and legislation, work with coalitions, and outreach to Congress, the White House, and relevant federal agencies.

ASPHO Endorses International Guidelines for HHT

Posted February 1, 2021

ASPHO endorsed the Second International HHT Guidelines for the Diagnosis and Management of HHT, published in the Annals of Internal Medicine, which provides new evidence-based consensus recommendations in six priority topic areas. The HHT Guidelines recommendations should facilitate the implementation of key components of HHT (Hereditary Hemorrhagic Telangiectasia) care into clinical practice.